Invesaro

Stocks Health care LFVN

NASDAQ · Health care

Lifevantage Corp (LFVN)

Lifevantage Corp reported revenue of $182.6M in fiscal 2026, down 20.1% from a year earlier. Net income was $5.1M, a net margin of 2.8%. Operating cash flow minus capital spending left $6.7M of free cash flow in fiscal 2026. At June 30, 2026 it held $14.9M in cash. Its latest periodic report to the SEC is the annual report (10-K) filed on August 27, 2026.

Free, no password. An email when LFVN files with the SEC.

Price
$4.88
-7.75% on the day · November 10, 2026
52-week range $3.90 to $11.71
Market cap
$61.6M
Revenue (FY2026)
$182.6M
-20.1% year on year
Net margin
2.8%
P/E
12.2
on FY2026 diluted EPS

Key facts about Lifevantage Corp

Net worth
Lifevantage Corp has a market value (market cap) of $61.6M at the latest share price, and shareholders' equity of $33.6M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2026 revenue was $182.6M (-20.1% year on year), with net income of $5.1M.
Cash flow
In fiscal 2026 operations brought in $10.2M of cash; after $3.6M of capital spending, free cash flow was $6.7M.
Latest report
The latest periodic report (annual report, 10-K) was filed with the SEC on August 27, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Lifevantage Corp's next report was expected around November 3, 2026 and is not on file with the SEC yet.
Dividend
Lifevantage Corp paid dividends of $0.19 per share in fiscal 2026, a yield of 3.79% at the current price.

What Lifevantage Corp does

Lifevantage Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker LFVN.

Revenue and profit by year

Revenue
FY19: $226M $226M FY19FY20: $232.9M $232.9M FY20FY21: $220.2M $220.2M FY21FY22: $206.4M $206.4M FY22FY23: $213.4M $213.4M FY23FY24: $200.2M $200.2M FY24FY25: $228.5M $228.5M FY25FY26: $182.6M $182.6M FY26
Net income
FY19: $7.4M $7.4M FY19FY20: $11.5M $11.5M FY20FY21: $12.9M $12.9M FY21FY22: $3.1M $3.1M FY22FY23: $2.5M $2.5M FY23FY24: $2.9M $2.9M FY24FY25: $9.8M $9.8M FY25FY26: $5.1M $5.1M FY26

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2026$182.6M$6.1M$5.1M$0.40$6.7M
2025$228.5M$12.2M$9.8M$0.75$10.5M
2024$200.2M$4.3M$2.9M$0.23$10M
2023$213.4M$4.3M$2.5M$0.20$3.8M
2022$206.4M$7.6M$3.1M$0.24$6.4M
2021$220.2M$17.6M$12.9M$0.90$12.5M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

A report was expected around November 3, 2026 and is not on file yet.

Estimated from its filing rhythm: 52 weeks after its report of November 4, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where LFVN ranks in Health care

Revenue$182.6M
#280 of 751 in Health care · Top 37%
Revenue growth-20.1%
#490 of 532 in Health care · Bottom 8%
Net margin2.8%
#186 of 544 in Health care · Top 34%
Free cash flow margin3.7%
#196 of 490 in Health care · Top 40%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

Lifevantage Corp paid $0.19 per share in fiscal 2026. At the current price that is a yield of 3.79%. It paid out $2.3M in cash dividends, 46% of its net income.

Fiscal yearPer sharePaid outOf profit
2026$0.19$2.3M46%
2025$0.17$2.1M21%
2024$0.55$6.9M236%
2023$0.13$1.6M62%
2022$0.03$378K12%
2021n/a$00%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Lifevantage Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 5, 2026
  2. September 18, 2026
  3. September 18, 2026
  4. September 18, 2026
  5. August 27, 2026
  6. August 27, 2026
    Annual report 10-K · period to June 30, 2026Revenue fell 20% to $182.6M versus the prior year; diluted EPS $0.40 versus $0.75.
  7. August 13, 2026
  8. August 3, 2026
  9. August 3, 2026
  10. July 29, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 5, 2026. Insider transactions on SEC

What is LFVN worth? A DCF from its reported cash flow

Insider trades

What the people running Lifevantage Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders bought $6.1K and sold $55.6K worth of shares in the last 90 days.

Bought (open market)
$6.1K
last 90 days
Sold
$55.6K
last 90 days
Net sold
8,025
$49.6K
DateInsiderWhatSharesPriceValueFiling
October 1, 2026 Cunningham KristenChief Sales Officer Shares withheld for tax 637 $6.24 $4K Form 4
October 1, 2026 Aure CarlChief Financial Officer Shares withheld for tax 460 $6.24 $2.9K Form 4
September 15, 2026 Lewis DarwinDirector Bought 976 $6.22 $6.1K Form 4
September 14, 2026 Cunningham KristenChief Sales Officer Sold 8,901 $6.18 $55K Form 4
September 11, 2026 Cunningham KristenChief Sales Officer Sold 100 $6.41 $641 Form 4
September 10, 2026 Cunningham KristenChief Sales Officer Shares withheld for tax 2,254 $6.37 $14.4K Form 4
September 10, 2026 Aure CarlChief Financial Officer Shares withheld for tax 1,869 $6.37 $11.9K Form 4
August 6, 2026 Moorehead TerrencePresident and CEO, Director Received as pay 308,642 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns LFVN

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
The Capital Management Corporation13G, passive 14.9% 1,878,411 July 6, 2026
Renaissance Technologies LLC13G, passive with 1 related filers 5.31% 669,418 August 13, 2026

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 89 managers reported a position.

HolderSharesValueChange on quarter
Capital Management Corp1,878,411$11.7M-563,508
Renaissance Technologies LLC669,418$4.2M-198,286
Vanguard Capital Management LLC429,203$2.7M-219
BlackRock, Inc.268,605$1.7M-501,093
Dimensional Fund Advisors LP256,296$1.6M-19,900
Envestnet Asset Management Inc229,907$1.4M+10,745
Susquehanna International Group, Llp169,046$1.1Mnew
American Century Companies Inc144,386$901K+39,722
Jane Street Group, LLC138,056$861.5Knew
Geode Capital Management, LLC120,830$754.3K-140,362
Aqr Capital Management LLC113,203$706.4K-42,893
Goldman Sachs Group Inc110,864$691.8K-74,250
Citadel Advisors LLC99,791$622.7K+23,281
Advyzon Investment Management, LLC85,827$535.6K-22,422
Indivisible Partners84,185$525.3K-22,669
Perkins Capital Management Inc75,458$470.9K0
Millennium Management LLC70,324$438.8Knew
Morgan Stanley65,284$407.4K-26,459
Barclays PLC64,901$405K+3,987
Vanguard Fiduciary Trust Co64,238$400.8K-3,353

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

9 insiders reported holding 1,770,944 shares in total, about $8.6M at the last price.

HolderSharesAs of
Fife Steven RPresident and CEO, Director 735,471 April 1, 2026
Moorehead TerrencePresident and CEO, Director 308,642 August 6, 2026
Aure CarlChief Financial Officer 156,035 October 1, 2026
Lewis DarwinDirector 138,244 September 15, 2026
Cunningham KristenChief Sales Officer 119,525 October 1, 2026
Neufeld AlissaGeneral Counsel 112,744 July 1, 2026
Dayton JuddDirector 80,359 March 2, 2026
Beindorff Michael ADirector 69,19541,625 held indirectly June 3, 2026
Thompson ToddChief Information Officer 50,729 December 23, 2025

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about LFVN

What does Lifevantage Corp do?

Lifevantage Corp is a company in the Health care sector, listed on NASDAQ as LFVN. Its shares trade on NASDAQ under the ticker LFVN.

What is Lifevantage Corp's net worth?

Lifevantage Corp has a market value (market cap) of $61.6M at the latest share price, and shareholders' equity of $33.6M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Lifevantage Corp profitable?

Yes. In fiscal 2026 it reported net income of $5.1M on revenue of $182.6M, a net margin of 2.8%.

How much revenue does Lifevantage Corp make?

In fiscal 2026 Lifevantage Corp reported revenue of $182.6M. That is 20.1% less than a year earlier.

When did Lifevantage Corp last report?

Its most recent periodic report is the annual report (10-K) filed on August 27, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the bylaws or fiscal year changed from October 5, 2026.

When is Lifevantage Corp's next earnings report?

Lifevantage Corp's next report was expected around November 3, 2026 and is not on file with the SEC yet.

Does Lifevantage Corp pay a dividend?

Yes. Lifevantage Corp paid dividends of $0.19 per share in fiscal 2026, a yield of 3.79% at the current price.

Similar companies

Compare LFVN with

Compare LFVN with any company

Follow LFVN

Get an email when Lifevantage Corp files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when LFVN files with the SEC.

Where the numbers come from

Financial figures are the values Lifevantage Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.